Background
Brian Rifkin
Potassium Rollercoaster Heartbreak

This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythmia.

Potassium Rollercoaster Heartbreak
Background
Jade Teakell
FLOZINATing to the Future- Long Term Effects of ...

This week, we will discuss post-trial follow-up for EMPA-Kidney. What are the longer-term effects of empagliflozin for patients with chronic kidney disease?

FLOZINATing to the Future- Long Term Effects of Empagliflozin in Patients with CKD
Background
Brian Rifkin
The Ondansetron Ballet: Torsades de Pointes

Nausea is a very common and distressing problem. Some medications that treat nausea carry a higher risk for arrhythmias, like Torsades de Pointes, and sudden cardiac death. Is ondansetron safe for use in patients on hemodialysis?

The Ondansetron Ballet: Torsades de Pointes
Background
Cristina Adriana Popa
Re”FINE”ing the role of non steroidal MRAs in ...

This week, we will discuss non-steroidal mineralocorticoid antagonist in the multiverse of cardiovascular-kidney-metabolic. What FINEHEART pooled analysis would add to what we already learned from FIDELIO-DKD trial?

Re”FINE”ing the role of non steroidal MRAs in Cardio Kidney Metabolic syndrome
Background
Cristina Adriana Popa
Playing It Safe: Can Felzartamab Fill the Gap ...

This week is time antibody mediated rejection treatment in kidney transplant. A new molecule targeting CD38, on the horizon, safely tested in a phase 2 trial

Playing It Safe: Can Felzartamab Fill the Gap in AMR Treatment?

tweetorial

Don't Stop Me Now!

If you missed the latest NephJC discussion, at least read the highlights here.

You gotta know when to hold’em and know when to fold’em. Review the #TenTweetNephJC for the STOP ACEi Trial, and always hold onto your ACEi.


Flozins strike again!

If you missed the biggest NephJC of the year, at least read the highlights here.

The future for refractory lupus nephritis?

Ten Tweet round up of exciting CAR T trial in patients with SLE discussed last month - check it out while you can!

What does the future look like in ADPKD?

Basic science week - catch up in only Ten Tweets here.

More diuretics = more diuresis

The ADVOR trial (adding acetazolamide in acute heart failure) is covered by #TenTweetNephJC

Is piperacillin-tazobactam nephrotoxic?

The debate continues, but this time with cystatin-C measurements. Read the #TenTweetNephJC summary here!

Speak volumes: #TenTweetNephJC wrap-up on CLASSIC

Intravenous fluids in sepsis - not exactly a rare treatment in a niche condition. Rapidly catch-up on this weeks journal club at the link for the take-home points.

SODIUM-HF: removing 'strict' from 'restriction'

If you missed out of the great #NephJC chat this week you can catch-up with our rapid 10 tweet summary.

Antibiotics and sudden cardiac death: #NephJC Tweetorial Catch-up

Which antibiotics increase risk of sudden death in your patient on haemodialysis? Probably something you should know. Check out our rapid-fire summary tweetorial at the link!

What is dd-cfDNA and how might it help?

Read the #TenTweetNephJC summary of the ADMIRAL study, examining how dd-cfDNA monitoring may help us manage our patients with renal transplants.

Ten Tweets does TESTING 2.0

Did you miss the TESTING reboot discussion? No worries, we have you covered here:

#TenTweetNephJC does CHAP

After CHIP we discussed CHAP. In case you missed it, we have you covered here:

Last time dwelling on PD peritonitis guidelines....

With guidelines as big as the latest ISPD whopper you can’t #TenTweetNephJC it - but check out the alternative NephJC summary tweetorial with some take home points below.

#TenTweetNephJC does PLEX in vasculitis

Want to learn more about the latest in using plasma exchange in ANCA-associated vasculitis? (if you’re a nephrologist, of course you do!)

Check out this rapid summary below!

You've been teaching diuretic resistance wrong for decades

This instalment of #TenTweetNephJC - the quickest way to stay up to date - recaps the recent NephJC chat on a mechanistic study investigating diuretic resistance, check it out at the link….

Acetaminophen and hypertension #TenTweetNephJC

The PATH-BP trial dropped - check out the results and the take from the #NephJC chats (in an <2 min summary)

Xenotransplantation summary tweetorial

You’ll have heard about the pig xenotransplant that did NOT show hyperacute rejection - check out the summary tweetorial of the need-to-know points from the study here.

When to start outpatient dialysis - #TenTweetNephJC summary

Third instalment of our NephJC summary tweetorials - catch it at the link to learn more about the trade-offs in timing when best to start dialysis in progressive CKD.

#TenTweetNephJC does PREDNOS-2

If you missed this weeks #NephJC chat and want a summary that takes less than 2 minutes to read, check out our second instalment by clicking the link!